Discovery of necrosis avidity of rhein and its applications in necrosis imaging
- 30 April 2020
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 28 (9) , 904-912
Abstract
Necrosis-avid agents possess exploitable theragnostic utilities including evaluation of tissue viability, monitoring of therapeutic efficacy as well as diagnosis and treatment of necrosis-related disorders. Rhein (4,5-dihydroxyl-2-carboxylic-9,10-dihydrodiketoanthracene), a naturally occurring monomeric anthraquinone compound extensively found in medicinal herbs, was recently demonstrated to have a newly discovered necrosis-avid trait and to show promising application in necrosis imaging. In this overview, we present the discovering process of rhein as a new necrosis-avid agent as well as its potential imaging applications in visualization of myocardial necrosis and early evaluation of tumor response to therapy. Moreover, the molecular mechanism exploration of necrosis avidity behind rhein are also presented. The discovery of necrosis avidity with rhein and the development of rhein-based molecular probes may further expand the scope of necrosis-avid compounds and highlight the potential utility of necrosis-avid molecular probes in necrosis imaging.Keywords
This publication has 79 references indexed in Scilit:
- Detection and quantification of acute reperfused myocardial infarction in rabbits using DISA-SPECT/CT and 3.0T cardiac MRIInternational Journal of Cardiology, 2013
- Imaging DNA with Fluorochrome Bearing MetalsInorganic Chemistry, 2013
- Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer ApplicationsJournal of Cancer, 2013
- Necrosis Avidity: A Newly Discovered Feature of Hypericin and its Preclinical Applications in Necrosis ImagingTheranostics, 2013
- Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor XenograftsTheranostics, 2013
- Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis ModelsTheranostics, 2012
- Molecular MRI of Acute Necrosis With a Novel DNA-Binding Gadolinium ChelateCirculation: Cardiovascular Imaging, 2011
- Hoechst-IR: An Imaging Agent That Detects Necrotic Tissue in Vivo by Binding Extracellular DNAOrganic Letters, 2010
- Hypericins as Potential Leads for New TherapeuticsInternational Journal of Molecular Sciences, 2010
- A DNA-binding Gd chelate for the detection of cell death by MRIChemical Communications, 2009